A Phase 2 Study of MZE829 in Adults With APOL1 Kidney Disease

Clinical trial NCT06830629 · RECRUITING

Trial details

NCT number: NCT06830629
Sponsor: Maze Therapeutics
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Proteinuric Kidney Disease

Start date: 2025-02-05
Primary completion: 2026-09-01
Enrollment: 74

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.